Latest other liabilities for AZRX: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
AzurRx BioPharma (AZRX) currently reports a other liabilities of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore AzurRx BioPharma's other liabilities history and peer comparisons.
AzurRx BioPharma's other liabilities changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
AzurRx BioPharma reported $0 in other liabilities as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AzurRx BioPharma, and consider following AZRX for alerts when major investors trade the stock.
AzurRx BioPharma is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AZRX with unrelated industries.